N.Korea boosts production of drugs, medical supplies to battle COVID
Reuters
Published May 18, 2022 10:26PM ET
Updated May 19, 2022 12:46AM ET
By Hyonhee Shin
SEOUL (Reuters) -North Korea is ramping up production of drugs and medical supplies including sterilisers and thermometers as it battles an unprecedented coronavirus outbreak, state media KCNA said on Thursday.
The isolated country, which has imposed a nationwide lockdown, is also increasing production of traditional Korean medicines used to reduce fever and pain, KCNA said, calling them "effective in prevention and cure of the malicious disease."
A sweeping COVID wave, which North Korea first confirmed last week, has fanned concerns over a lack of medical resources and vaccines, with the U.N. human rights agency warning of "devastating" consequences for its 25 million people.
The outbreak spread after Pyongyang held a massive military parade on April 25 and was expected to peak between late May and early June, South Korea's Newsis news agency said on Wednesday, citing lawmakers briefed by Seoul's spy agency.
KCNA had said only that a wave of fever of unidentified origin began in late April.
At least 262,270 more people reported fever symptoms, and one additional person died as of Wednesday evening, KCNA said, citing data from the state emergency epidemic prevention headquarters. It did not specify how many people had tested positive for the virus.
North Korea has so far reported 1,978,230 people with fever symptoms and 63 deaths, and imposed strict anti-virus measures.
Factories are churning out more injections, medicines, thermometers and other medical supplies in the capital Pyongyang and nearby regions "in a lightning way," while more isolation wards were installed and disinfection work intensified around the country, KCNA said.
"Thousands of tons of salt were urgently transported to Pyongyang City to produce antiseptic solution," KCNA said.
The reports came after North Korean leader Kim Jong Un criticised ineffective distribution of drugs and slammed officials for their "immature" responses to the epidemic.
Without a national vaccination campaign and COVID treatment, state media have encouraged patients to use painkillers and antibiotics as well as unverified home remedies, such as gargling salt water, or drinking lonicera japonica tea or willow leaf tea.
North Korea's state television recommended wearing two masks outdoors, a practice Kim followed on a weekend pharmacy visit, though not in TV images of a politburo meeting of the ruling Workers' Party on Tuesday.
Dale Fisher, a professor of medicine at National University of Singapore, said the crisis might be underestimated because of the absence of testing and the more asymptomatic Omicron variant, and could cause greater social and economic fallout in an unvaccinated community.
"The best health systems in the world struggled in most countries, so I think it's likely that the true health impact is not being accurately described," Fisher said.
Get The News You Want
"An urgent vaccine rollout is imperative, and significant public health measures and social interventions should be introduced in the meantime to slow the spread," he added.
South Korea and the United States have respectively offered to help North Korea fight the virus, including sending aid, but have not received a response, Seoul's deputy national security advisor said on Wednesday.
However, three aircraft from North Korea's Air Koryo arrived in China and returned to Pyongyang on Monday carrying medical supplies, a diplomatic source said on condition of anonymity.
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.